4.6 Review

The Sweet Side of HIPK2

Journal

CANCERS
Volume 15, Issue 10, Pages -

Publisher

MDPI
DOI: 10.3390/cancers15102678

Keywords

hyperglycemia; diabetes; p53; apoptosis; drug resistance; HIF-1; hypoxia; microRNA; cancer; diabetic complications

Categories

Ask authors/readers for more resources

HIPK2 is a protein kinase that plays a crucial role in various cellular functions and molecular pathways. It is involved in cancer cell response to cytotoxic drugs, regulation of fibrosis, angiogenesis, and neurological diseases. Recent studies have found that HIPK2 activity can be influenced by hyperglycemia, affecting cancer cell response to chemotherapy and the progression of diabetes complications.
HIPK2 is an evolutionary conserved protein kinase which modulates many molecular pathways involved in cellular functions such as apoptosis, DNA damage response, protein stability, and protein transcription. HIPK2 plays a key role in the cancer cell response to cytotoxic drugs as its deregulation impairs drug-induced cancer cell death. HIPK2 has also been involved in regulating fibrosis, angiogenesis, and neurological diseases. Recently, hyperglycemia was found to positively and/or negatively regulate HIPK2 activity, affecting not only cancer cell response to chemotherapy but also the progression of some diabetes complications. The present review will discuss how HIPK2 may be influenced by the high glucose (HG) metabolic condition and the consequences of such regulation in medical conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available